652
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Atrial fibrillation incidence after coronary artery bypass graft surgery and percutaneous coronary intervention: the prospective AFAF cohort study

, , , , &
Article: 2347297 | Received 02 Oct 2023, Accepted 20 Apr 2024, Published online: 02 May 2024

References

  • Stewart S, Hart CL, Hole DJ, et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113(5):359–364. doi: 10.1016/s0002-9343(02)01236-6.
  • Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991;22(8):983–988. doi: 10.1161/01.str.22.8.983.
  • Ahlsson A, Fengsrud E, Bodin L, et al. Postoperative atrial fibrillation in patients undergoing aortocoronary bypass surgery carries an eightfold risk of future atrial fibrillation and a doubled cardiovascular mortality. Eur J Cardiothorac Surg. 2010;37(6):1353–1359. doi: 10.1016/j.ejcts.2009.12.033.
  • Ahlsson A, Bodin L, Fengsrud E, et al. Patients with postoperative atrial fibrillation have a doubled cardiovascular mortality. Scand Cardiovasc J. 2009;43(5):330–336. doi: 10.1080/14017430802702291.
  • Villareal RP, Hariharan R, Liu BC, et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol. 2004;43(5):742–748. doi: 10.1016/j.jacc.2003.11.023.
  • Mariscalco G, Klersy C, Zanobini M, et al. Atrial fibrillation after isolated coronary surgery affects late survival. Circulation. 2008;118(16):1612–1618. doi: 10.1161/CIRCULATIONAHA.108.777789.
  • Fengsrud E, Englund A, Ahlsson A. Pre- and postoperative atrial fibrillation in CABG patients have similar prognostic impact. Scand Cardiovasc J. 2017;51(1):21–27. doi: 10.1080/14017431.2016.1234065.
  • SWEDEHART. SWEDEHART annual report 2021: SWEDEHEART Registry; 2021. Available from: https://www.ucr.uu.se/swedeheart/dokument-sh/arsrapporter-sh/1-swedeheart-annual-report-2021-english/viewdocument/3384
  • Kosmidou I, Chen S, Kappetein AP, et al. New-onset atrial fibrillation after PCI or CABG for left main disease: the EXCEL trial. J Am Coll Cardiol. 2018;71(7):739–748. doi: 10.1016/j.jacc.2017.12.012.
  • Potdar SP, Shales S, Baviskar M, et al. Incidence, predictors, and outcome for post-operative atrial fibrillation in Indian patients undergoing off-pump coronary artery bypass grafting–a prospective observational study. Indian J Thorac Cardiovasc Surg. 2022;38(4):366–374. doi: 10.1007/s12055-022-01358-7.
  • Rene AG, Genereux P, Ezekowitz M, et al. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial). Am J Cardiol. 2014;113(2):236–242. doi: 10.1016/j.amjcard.2013.09.016.
  • Association WM. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194.
  • Doliwa PS, Frykman V, Rosenqvist M. Short-term ECG for out of hospital detection of silent atrial fibrillation episodes. Scand Cardiovasc J. 2009;43(3):163–168. doi: 10.1080/14017430802593435.
  • Doliwa PS, Rosenqvist M, Frykman V. Paroxysmal atrial fibrillation with silent episodes: intermittent versus continuous monitoring. Scand Cardiovasc J. 2012;46(3):144–148. doi: 10.3109/14017431.2012.661873.
  • Doliwa Sobocinski P, Anggardh Rooth E, Frykman Kull V, et al. Improved screening for silent atrial fibrillation after ischaemic stroke. Europace. 2012;14(8):1112–1116. doi: 10.1093/europace/eur431.
  • Kolh P, Windecker S, Alfonso F, et al. ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg. 2014;46(4):517–592.
  • Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg. 2016;50(5):e1–e88. doi: 10.1016/j.rec.2016.11.033.
  • Chan W, Ajani AE, Clark DJ, et al. Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention. Am J Cardiol. 2012;109(4):471–477. doi: 10.1016/j.amjcard.2011.10.004.
  • Lopes RD, Elliott LE, White HD, et al. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. Eur Heart J. 2009;30(16):2019–2028. doi: 10.1093/eurheartj/ehp213.
  • Mrdovic I, Savic L, Krljanac G, et al. Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention: insight into the RISK-PCI trial. Coron Artery Dis. 2012;23(1):1–8. doi: 10.1097/MCA.0b013e32834df552.
  • Pilgrim T, Kalesan B, Zanchin T, et al. Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents. EuroIntervention. 2013;8(9):1061–1071. doi: 10.4244/EIJV8I9A163.
  • Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961–972. doi: 10.1056/NEJMoa0804626.
  • Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012;367(25):2375–2384. doi: 10.1056/NEJMoa1211585.
  • Boriani G, Glotzer TV, Santini M, et al. Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices). Eur Heart J. 2014;35(8):508–516. doi: 10.1093/eurheartj/eht491.
  • Friberg L, Rosenqvist M, Lindgren A, et al. High prevalence of atrial fibrillation among patients with ischemic stroke. Stroke. 2014;45(9):2599–2605. doi: 10.1161/STROKEAHA.114.006070.
  • Hendrikx T, Hornsten R, Rosenqvist M, et al. Screening for atrial fibrillation with baseline and intermittent ECG recording in an out-of-hospital population. BMC Cardiovasc Disord. 2013;13:41. doi: 10.1186/1471-2261-13-41.
  • Hendrikx T, Rosenqvist M, Wester P, et al. Intermittent short ECG recording is more effective than 24-hour Holter ECG in detection of arrhythmias. BMC Cardiovasc Disord. 2014;14:41. doi: 10.1186/1471-2261-14-41.
  • Sandgren E, Wickbom A, Kalm T, et al. The contribution of intermittent handheld electrocardiogram and continuous electrocardiogram monitoring with an implantable loop recorder to detect incident and recurrent atrial fibrillation during 1 year after coronary artery bypass graft surgery: a prospective cohort study. Heart Rhythm O2. 2021;2(3):247–54. doi: 10.1016/j.hroo.2021.05.001.
  • Dal Zotto B, Barbieri L, Tumminello G, et al. New onset atrial fibrillation in STEMI patients: main prognostic factors and clinical outcome. Diagnostics. 2023;13(4):613. doi: 10.3390/diagnostics13040613.
  • Ahlsson AJ, Bodin L, Lundblad OH, et al. Postoperative atrial fibrillation is not correlated to C-reactive protein. Ann Thorac Surg. 2007;83(4):1332–1337. doi: 10.1016/j.athoracsur.2006.11.047.
  • Wu M, Gu X, Li X, et al. C-reactive protein and inflammatory cytokines during percutaneous coronary intervention. J Vasc Res. 2016;53(1–2):39–48. doi: 10.1159/000447558.
  • Kinoshita T, Asai T, Takashima N, et al. Preoperative C-reactive protein and atrial fibrillation after off-pump coronary bypass surgery. Eur J Cardiothorac Surg. 2011;40(6):1298–1303.
  • Patel P, Dokainish H, Tsai P, et al. Update on the association of inflammation and atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21(9):1064–1070. doi: 10.1111/j.1540-8167.2010.01774.x.
  • Friedrichs K, Klinke A, Baldus S. Inflammatory pathways underlying atrial fibrillation. Trends Mol Med. 2011;17(10):556–563. doi: 10.1016/j.molmed.2011.05.007.
  • Imazio M, Brucato A, Ferrazzi P, et al. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial. JAMA. 2014;312(10):1016–1023. doi: 10.1001/jama.2014.11026.
  • Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498. doi: 10.1093/eurheartj/ehaa612.
  • Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1):e1–e156.
  • Butt JH, Xian Y, Peterson ED, et al. Long-term thromboembolic risk in patients with postoperative atrial fibrillation after coronary artery bypass graft surgery and patients with nonvalvular atrial fibrillation. JAMA Cardiol. 2018;3(5):417–424. doi: 10.1001/jamacardio.2018.0405.
  • Chapin TW, Leedahl DD, Brown AB, et al. Comparison of anticoagulants for postoperative atrial fibrillation after coronary artery bypass grafting: a pilot study. J Cardiovasc Pharmacol Ther. 2020;25(6):523–530. doi: 10.1177/1074248420929483.
  • Batra G, Ahlsson A, Lindahl B, et al. Atrial fibrillation in patients undergoing coronary artery surgery is associated with adverse outcome. Ups J Med Sci. 2019;124(1):70–77. doi: 10.1080/03009734.2018.1504148.